Celltrio is a company that focuses on accelerating research, drug discovery, and scientific breakthroughs through the fastest path to cell culturing system automation. By leveraging modularity, the company automates manual processes involved in raw cell division to harvesting cultured cells. The flexibility in combining standard task module machines, robots, and software allows for a tailored cell culturing lab automation solution. Celltrio stands out as the sole developer of a complete range of stand-alone manual cell storage, culturing, and harvesting machines, designed to be automated by their own robots. This scalability and precision are aimed at reducing drug or novel cell development time-to-market, decreasing costs, and enhancing quality. The company's offerings include modular cell culturing automation and cryogenic freezer solutions, detailed on their website www.celltrio.com. For further information, contacting [email protected] promises a prompt response. Founded in 2018, Celltrio operates in the industries of Information Technology, Manufacturing, and Robotics. Currently, there is no disclosed information regarding its last investment or investors.
There is no investment information
No recent news or press coverage available for Celltrio.